SCHEMBL587272

SCHEMBL587272

NNc1ccc(C(F)(F)F)cn1

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 2/20 0.53
RAB9A P51151 7/20 0.49
NPC1 O15118 5/20 0.49
KMT2A Q03164 4/20 0.47
GAA P10253 3/20 0.46
MEN1 O00255 3/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
CDK5 Q00535 3/20 0.46
CDK5R1 Q15078 3/20 0.46
MAPT P10636 2/20 0.46
GFER P55789 1/20 0.46
ALDH1A1 P00352 2/20 0.45
POLB P06746 2/20 0.45
LMNA P02545 1/20 0.45
XPO1 O14980 1/20 0.45
TDP1 Q9NUW8 1/20 0.44
RPS6KA3 P51812 1/20 0.43
DEGS1 O15121 1/20 0.42
HTT P42858 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29525907 1.00 PTGS1 (0.53) PTGS1RAB9ANPC1KMT2AGAA
Hydrochloric Acid SCHEMBL15167588 0.98 PTGS1 (0.51) PTGS1RAB9ANPC1KMT2AGAA
Hydrochloric Acid SCHEMBL30062287 0.98 PTGS1 (0.51) PTGS1RAB9ANPC1KMT2AGAA
SCHEMBL8989471 0.83 RAB9A (0.51) PTGS1RAB9ANPC1KMT2AGAA
SCHEMBL16343351 0.81 CSF1R (0.44) PTGS1RAB9ANPC1DEGS1
SCHEMBL16343658 0.81 PTGS1 (0.44) PTGS1RAB9ANPC1KMT2AGAA
SCHEMBL16343659 0.81 PTGS1 (0.44) PTGS1RAB9ANPC1KMT2AGAA
SCHEMBL16343747 0.81 TAAR1 (0.49) PTGS1DEGS1
Ethoxycarbonyl Group SCHEMBL28282913 0.81 GAA (0.51) PTGS1RAB9ANPC1KMT2AGAA
SCHEMBL116298 0.79 RAB9A (0.49) PTGS1RAB9ANPC1KMT2AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 267 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118955469-A Pyrazole alcohol compound as well as preparation method and application thereof 安徽中医药大学 2024-11-15 CN claimed
EP-3983411-B1 FUSED HETEROCYCLIC COMPOUNDS AND THEIR USE AS PEST CONTROL AGENTS PI INDUSTRIES LTD (IN) 2026-05-27 EP disclosed
EP-4745134-A1 PROTEIN ARGINASE METHYLTRANSFERASE-5 INHIBITOR AND MEDICAL USE THEREOF Jiangsu Yahong Meditech Co., Ltd. (CN) 2026-05-20 EP disclosed
US-20260022131-A1 4-PHENYLPIPERIDINES, THEIR PREPARATION AND USE THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2026-01-22 US disclosed
EP-4163277-B1 NOVEL PYRAZOLE DERIVATIVES APTABIO THERAPEUTICS INC (KR) 2026-01-14 EP disclosed
US-12509438-B2 Pyrazole derivative APTABIO THERAPEUTICS INC. (KR) 2025-12-30 US disclosed
US-12473302-B2 4-phenylpiperidines, their preparation and use THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2025-11-18 US disclosed
US-12384787-B2 Fused heterocyclic compounds and their use as pest control agents PI INDUSTRIES LTD (IN) 2025-08-12 US disclosed
CN-115734965-B Aryltetrahydropyridazine derivatives or salts thereof, and insecticides containing the same and methods of use thereof 日本农药株式会社 2025-05-02 CN disclosed
CN-118126023-B Pyrazole amide compound as well as preparation method and application thereof 安徽中医药大学 2025-04-11 CN disclosed
WO-2002030923-A1 NOVEL AMINOTRIAZOLONE COMPOUNDS, METHOD FOR PREPARING SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME LES LABORATOIRES SERVIER (FR) 2002-04-18 WO disclosed
US-6265431-B1 ANTICHOLESTEROL DRUGS BAYER AKTIENGESELLSCHAFT (DE) 2001-07-24 US disclosed
US-6245775-B1 ANTICHOLESTEROL AGENTS; CARDIOVASCULAR DISORDERS BAYER AKTIENGESELLSCHAFT (DE) 2001-06-12 US disclosed
EP-1103547-A1 FORMAZAN METAL COMPLEX Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo (JP) 2001-05-30 EP disclosed
EP-0680954-B1 Process of preparation of 1-(Het)aryl-3-hydroxy pyrazoles BASF AG (DE) 2000-11-22 EP disclosed
US-5684014-A FOR TREATING ATHEROSCLEROSIS BAYER AKTIENGESELLSCHAFT (DE) 1997-11-04 US disclosed
US-5569763-A USEFUL AS ORGANIC NONLINEAR OPTICAL MATERIAL AND A HIGHLY SENSITIVE COLORING CHELATION AGENT KABUSHIKI KAISHA TOSHIBA (JP) 1996-10-29 US disclosed
US-5559244-A Preparation of 1-(het) aryl-3-hydroxypyrazoles BASF AKTIENGESELLSCHAFT (DE) 1996-09-24 US disclosed
EP-0705831-A2 Cycloalkano-indole- and -azaindole derivatives BAYER AG (DE) 1996-04-10 EP disclosed
EP-0680954-A2 Process of preparation of 1-(Het)aryl-3-hydroxy pyrazoles BASF AKTIENGESELLSCHAFT (DE) 1995-11-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12473302-B2 4-phenylpiperidines, their preparation and use HTR3C, HRH4, DRD3 PTGS1 2691/4885RAB9A 1612/4885NPC1 3005/4885
US-12384787-B2 Fused heterocyclic compounds and their use as pest control agents DDT, ACHE, KEAP1 PTGS1 1070/4885RAB9A 29/4885NPC1 3338/4885
US-12509438-B2 Pyrazole derivative CBR3, NR3C2, NR3C1 PTGS1 1776/4885RAB9A 1143/4885NPC1 1104/4885
US-20260022131-A1 4-PHENYLPIPERIDINES, THEIR PREPARATION AND USE CLN6, NR2E3, CBR3 PTGS1 1692/4885RAB9A 1209/4885NPC1 12/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.